Navigation Links
AstraZeneca Accepts Secretary of Defense Award for Supporting Employees Serving in National Guard and Reserve
Date:9/17/2009

WILMINGTON, Del., Sept. 17 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) accepted the 2009 Secretary of Defense Employer Support Freedom Award on Thursday at a ceremony in Washington, D.C. This award is the highest recognition given by the U.S. government to employers for their outstanding support of employees who serve in the National Guard and Reserve.

AstraZeneca US President Rich Fante accepted the award on behalf of AstraZeneca and was joined by AstraZeneca Vice President of Human Resources, Marta Perez, and members of the company's Military Support Employee Network Group.

"I am proud of how AstraZeneca leaders and employees are supporting not only their colleagues who serve in the National Guard and Reserve, but also their families and community members," Fante, a former Army Reservist, said.

AstraZeneca was nominated for the award by an employee from New Jersey, a current U.S. Army Reserve lieutenant colonel who has served in Afghanistan and Iraq. The company employs more than 100 men and women serving in the National Guard or Reserve, and was one of 15 employers chosen for this award from among more than 3,200 total nominations.

AstraZeneca provides flexible policies and benefits designed to ease burdens on employees serving in the National Guard or Reserve, including:

  • Providing the difference between a service member's regular pay and military pay for military service up to 24 months, after which time each employee's situation is reviewed on a case-by-case basis
  • Offering continuation of health and dental insurance for periods of military service greater than 12 months. Additionally, company-provided life insurance continues for one year after the start of the military leave and can be converted to a private plan after one year
  • Fostering a Military Support Employee Network Group, which is made up of 200 members including National Guard members and Reservists, employees who are veterans, employees whose family members are either veterans or who are currently in the service, plus employees who want to show their support of troops
  • Maintaining contact with the families of Guard and Reserve employees during periods of military service

The Freedom Award was instituted in 1996 under the auspices of the National Committee for Employer Support of the Guard and Reserve (ESGR) to recognize exceptional support from the employer community.

AstraZeneca has received numerous ESGR state awards for its support for National Guard and Reserve employees, including several Patriot Awards, the Above and Beyond Award and the Pro Patria Award.

About AstraZeneca

AstraZeneca is engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and in the supply of healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with global healthcare sales of $31.6 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines. In the United States, AstraZeneca is a $13.5 billion dollar healthcare business.

For more information about AstraZeneca in the US or our AZ&Me(TM) Prescription Savings programs, please visit: www.astrazeneca-us.com.


'/>"/>
SOURCE AstraZeneca
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Video: AstraZeneca Traveling Exhibit Helps Americans Understand and Manage Bipolar Depression
2. AstraZeneca and the Artery Explorer Take California Residents on Virtual Journey Through the Arteries
3. AstraZeneca Submits New Drug Applications for ZACTIMA(TM) in Second-Line Advanced Non-Small Cell Lung Cancer
4. AstraZeneca Expands Prescription Savings Program
5. AstraZeneca Partners With Primary Health Care to Help Iowa Uninsured
6. AstraZeneca and Mental Health Research Institute in Australia Announce Collaboration to Improve Early Detection of Alzheimers Disease
7. Abbott and AstraZeneca Extend Relationship to Include Co-Promotion of TRILIPIX(R) (fenofibric acid)
8. Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD(TM), an Investigational Treatment for Mixed Dyslipidemia
9. AstraZeneca Studies Show Relief of Nighttime Heartburn and Reduction in GERD-Related Sleep Disturbances
10. Verus Pharmaceuticals Announces a Lawsuit Against AstraZeneca AB and Tika Lakemedel AB
11. Court Grants AstraZeneca Preliminary Injunction Against Apotex in PULMICORT RESPULES Patent Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... 2017 , ... The National Business Research Institute (NBRI) is ... Emergency Medical Technicians and welcomes this organization to the NBRI Circle of ... Ph.D. , CEO & Organizational Psychologist at NBRI. “This award is a result ...
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you BioEnergy which ... nutrients from SUPERFOODS! , RawTrition is taking nutrients to the next level! ... the body recognizes its raw form (unlike the synthetically made options that are on ...
(Date:4/26/2017)... Pa. (PRWEB) , ... April ... ... division, which provides an agile ecosystem and domain expertise for sponsors and ... configurable randomization and trial supply management (RTSM) software platform. Bioclinica AGILE ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... collaboration, announces Mirroring360 Pro . This new addition to the Mirroring360 product ... for education and business. , Mirroring360 Pro enables educators, business professionals and individuals ...
(Date:4/25/2017)... ... 25, 2017 , ... A stressful work environment can hurt the physical and ... and performance in the workplace. The goal of Clearview Resolution Services has always been ... April, Clearview Resolution Services will be shutting down the office early on Fridays. The ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 Global ... This report on the prostate cancer therapeutics market ... global market. Increasing prevalence of prostate cancer, launch ... in the development of new drugs & therapeutic ... cancer drug due to lesser side effects are ...
(Date:4/19/2017)... , April 19, 2017  New research provides evidence that ... Parkinson,s, according to a study released today that will be ... Meeting in Boston , April 22 ... the treatment of Parkinson,s disease, the oral drug levodopa has ... and longevity. But as the disease progresses, the effects of ...
(Date:4/18/2017)... April 18, 2017 Viverae ® , a ... the integration of IBM ® Watson Campaign Automation, ... targeted communications for a personalized experience. Through digital engagement, ... their health in real time. The enhanced experience drives ... to members, wherever they are in their journey to ...
Breaking Medicine Technology: